FHTX · Foghorn Therapeutics Inc.

$4.84 -0.23 (-4.54%) At close · Jul 24

Market Cap

$284.76M

58.71M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Gottschalk	CEO	$638,000	—	—	$1,334,037	$385,990	$3,000	$2,361,027
Steven Bellon	Chief Scientific Officer	$505,000	—	—	$469,255	$222,200	$3,000	$1,199,455

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kristian Humer	CFO	$336,458	$87,000	—	$1,250,797	$161,500	$52,848	$1,888,603
Adrian Gottschalk	CEO	$601,500	—	—	$673,861	$281,201	$3,000	$1,559,562
Anna Rivkin	Chief Business Officer	$143,333	$135,000	—	$1,123,912	$48,733	$21,606	$1,472,584
Steven Bellon	Chief Scientific Officer	$485,000	—	—	$249,312	$164,900	$3,000	$902,212

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Gottschalk	CEO	$579,000	—	—	$1,719,292	$202,650	$3,000	$2,503,942
Steven Bellon	Chief Scientific Officer	$445,000	—	—	$614,894	$124,600	$3,000	$1,187,494

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Gottschalk	CEO	$575,000	—	—	$4,645,819	$215,625	—	$5,436,444
Steven Bellon	Chief Scientific Officer	$435,000	—	—	$1,580,167	$130,500	—	$2,145,667
Michael LaCascia	Chief Legal Officer	$435,000	—	—	$1,422,677	$130,500	—	$1,988,177
Allan Reine	CFO	$435,000	—	—	$1,421,769	$130,500	—	$1,987,269

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Gottschalk	CEO	$540,000	—	—	$3,370,482	$405,000	—	$4,315,482
Allan Reine	CFO	$416,000	—	—	$1,348,746	$249,600	—	$2,014,346
Samuel Agresta	Chief Medical Officer	$428,500	—	—	$1,124,004	$257,100	—	$1,809,604
Carl P. Decicco	Chief Scientific Officer	$428,500	—	—	$1,124,004	$257,100	—	$1,809,604

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Gottschalk	CEO	$478,950	—	—	$1,834,007	$311,318	—	$2,624,275
Michael LaCascia	Chief Legal Officer	$59,423	$60,000	—	$1,869,416	—	—	$1,988,838
Carl P. Decicco	Chief Scientific Officer	$412,000	—	—	$542,224	$214,240	$50,000	$1,218,464
Samuel Agresta	Chief Medical Officer	$412,000	—	—	$542,224	$99,573	—	$1,053,797

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carl P. Decicco	Chief Scientific Officer	$400,000	—	—	$1,474,337	$136,000	$60,000	$2,070,337
Adrian Gottschalk	CEO	$465,000	—	—	$642,918	$197,625	—	$1,305,543
Samuel Agresta	Chief Medical Officer	$116,667	$300,000	—	$785,607	—	—	$1,202,274

Key facts CIK 1822462 CUSIP 344174107 13F (30d) 13 filings 13 filers Visit website Investor relations